Related Experiment Video
Updated: Jul 7, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Invasive pneumococcal disease surveillance in Canada, 2020
Alyssa Golden1, Averil Griffith1, Walter Demczuk1
1National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Invasive pneumococcal disease (IPD) incidence declined in Canada in 2020. However, prevalence of certain vaccine-type and non-vaccine type serotypes, alongside multidrug resistance, increased, necessitating ongoing surveillance.
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- Invasive pneumococcal disease (IPD) is a significant public health concern in Canada.
- While conjugate vaccines have reduced overall IPD incidence, shifts in serotype distribution towards non-vaccine types are observed.
- This report details IPD demographics, serotypes, and antimicrobial resistance in Canada for 2020.
Purpose of the Study:
- To summarize the epidemiological characteristics of IPD in Canada in 2020.
- To analyze serotype distribution and trends in IPD cases.
- To assess antimicrobial resistance patterns among IPD isolates.
Main Methods:
- National surveillance data for IPD isolates were collected from Canadian public health laboratories in 2020.
- Serotyping was performed using the Quellung reaction.
- Antimicrobial susceptibilities were determined, and incidence rates were calculated using the Canadian Notifiable Disease Surveillance System.
Main Results:
- Overall IPD incidence decreased from 2019 to 2020 across all age groups.
- Serotypes 4, 3, and 8 were the most common overall.
- Trends showed increasing prevalence of serotypes 4, 3, 8, and 12F from 2016-2020.
- Prevalence of PCV13 serotypes increased, as did multidrug-resistant IPD.
Conclusions:
- Despite a decrease in overall IPD incidence in 2020, specific serotypes (3, 4, 8, 12F) and multidrug resistance showed concerning increases.
- Continued national surveillance is crucial for monitoring evolving serotype distribution and antimicrobial resistance patterns of IPD.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Principles of Disease Surveillance
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

